S100A11 and central nervous system cancer: Recent studies reported that S100A11 was an oncogene in pancreatic ductal adenocarcinoma 1,2, glioma 3-5, colorectal cancer 6, breast cancer 7, lung cancer 8, thyroid cancer 9, and gastric cancer 10.